Sanofi and GSK to support COVAX with 200 million doses of adjuvanted, recombinant protein-based COVID-19 vaccineGlobeNewsWire • 10/28/20
Sanofi and Translate Bio Have a COVID-19 Vaccine Candidate Ready for Clinical TrialsThe Motley Fool • 10/15/20
Sanofi, Translate Bio Post Positive Early Covid-19 Vaccine Results; Plan Human TestingInvestors Business Daily • 10/15/20
Sanofi and Translate Bio mRNA COVID-19 vaccine candidate induced high antibody levels in preclinical studiesGlobeNewsWire • 10/15/20
There are seven coronavirus vaccine candidates being tested in the U.S. — here’s where they standMarket Watch • 10/14/20
Sanofi, Regeneron Report Positive Phase 3 Results For Asthma Drug Dupixent's Use In ChildrenBenzinga • 10/13/20
Sanofi: Information concerning the total number of voting rights and shares - August 2020GlobeNewsWire • 10/01/20
Sanofi CEO Says COVID-19 Vaccine Development Process Accelerated, Not Side-SteppedBenzinga • 09/25/20
Sanofi isn't cutting corners in coronavirus vaccine development despite acceleration, CEO saysCNBC • 09/24/20
Sanofi, GlaxoSmithKline signs deal with Canada to deliver 72 million doses of potential COVID-19 vaccineMarket Watch • 09/22/20
Sanofi and GSK sign agreements with the Government of Canada to supply up to 72 million doses of adjuvanted COVID-19 vaccineGlobeNewsWire • 09/22/20
Hart-Scott-Rodino waiting period expires for Sanofi’s acquisition of Principia Biopharma Inc.GlobeNewsWire • 09/22/20